MyFinsight

HomeCompareAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Privacy Policy
  • Contact

Follow Us

  • Thread
  • X.com
  • Instagram

© 2026 MyFinsight. All rights reserved.

Recent SEC Filings
10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)
XFOR Cash Flow Sankey DiagramSankey diagram visualizing XFOR cash flow for the periodProceeds from issuance ofshares of common stock...$74K (60.87%↑ Y/Y)Proceeds from sales ofshares of common stock,...$1K (-99.98%↓ Y/Y)Net cash provided byfinancing activities$75K (-98.67%↓ Y/Y)Net decrease incash, cash...-$21,718K (-32.00%↓ Y/Y)Canceled cashflow$75K Stock-based compensationexpense$3,086K (143.57%↑ Y/Y)Depreciation andamortization expense$997K (19.98%↑ Y/Y)Deferred revenue$408K (-74.19%↓ Y/Y)Non-cash lease expense$381K (-73.15%↓ Y/Y)Accretion of debt discount$239K (-45.31%↓ Y/Y)Sales and maturitiesof marketable...$4,000K (-89.98%↓ Y/Y)Net cash used inoperating activities-$20,788K (50.82%↑ Y/Y)Net cash provided byinvesting activities-$1,000K (-105.01%↓ Y/Y)Canceled cashflow$5,111K Canceled cashflow$4,000K Effect of exchange ratechanges on cash, cash...-$5K (-102.37%↓ Y/Y)Net loss-$16,157K (36.54%↑ Y/Y)Prepaid expenses, othercurrent and non-current...$3,017K (784.13%↑ Y/Y)Accrued expenses andother long-term...-$2,931K (61.20%↑ Y/Y)Acquisition of intangibleasset$5,000K (66.67%↑ Y/Y)Accounts payable-$1,140K (-17.89%↓ Y/Y)Accounts receivable$934K (1145.33%↑ Y/Y)Inventory$865K (145.04%↑ Y/Y)Change in fair value ofwarrant liability-$528K (96.08%↑ Y/Y)Lease liabilities-$268K (52.14%↑ Y/Y)Other$59K (130.10%↑ Y/Y)

X4 Pharmaceuticals, Inc (XFOR)

X4 Pharmaceuticals, Inc (XFOR)

Cash Flow
Quarterly Cash Flow Statement for the quarter ending in 2026-06-30
source: myfinsight.com